Nexus Pharmaceuticals’ planned facility takes aim at drug shortages
Illinois-based Nexus Pharmaceuticals said last month that it plans to build a sterile drug manufacturing facility in Pleasant Prairie.
To access this content, you must purchase a Premium membership, or log in if you are a member.
